{
    "organizations": [],
    "uuid": "2dafede4bd87e289d3e5695d34ad817de481bbff",
    "author": "",
    "url": "https://www.reuters.com/article/brief-abbvie-receives-positive-recommend/brief-abbvie-receives-positive-recommendation-from-canadian-drug-committee-for-maviret-idUSFWN1PW0OH",
    "ord_in_thread": 0,
    "title": "BRIEF-AbbVie Receives Positive Recommendation From Canadian Drug Committee For Maviret",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "  6 minutes BRIEF-AbbVie Receives Positive Recommendation From Canadian Drug Committee For Maviret Reuters Staff 1 Min Read \nFeb 6 (Reuters) - AbbVie Inc: \n* ABBVIE RECEIVES A POSITIVE RECOMMENDATION FROM THE CADTH CANADIAN DRUG EXPERT COMMITTEE FOR MAVIRETâ„¢ - AN ORAL THERAPY FOR THE TREATMENT OF PATIENTS WITH HEPATITIS C  ",
    "published": "2018-02-06T16:08:00.000+02:00",
    "crawled": "2018-02-06T16:22:25.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "minute",
        "receives",
        "positive",
        "recommendation",
        "canadian",
        "drug",
        "committee",
        "maviret",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "abbvie",
        "inc",
        "abbvie",
        "receives",
        "positive",
        "recommendation",
        "cadth",
        "canadian",
        "drug",
        "expert",
        "committee",
        "oral",
        "therapy",
        "treatment",
        "patient",
        "hepatitis",
        "c"
    ]
}